Published: Jun 09, 2026 Category Social Media Source https://www.instagram.com/p/DZXssawFsfG/ Details In ATTR-CM, acoramidis increased serum TTR and reduced CV death/hospitalization in ATTRibute-CM.Early rises in TTR were linked to lower risk, suggesting sTTR may be a useful biomarker of treatment response.
